Obsessive-Compulsive Disorder
Compulsive Behavior
Compulsive Personality Disorder
Implosive Therapy
Tourette Syndrome
Fluvoxamine
Obsessive Behavior
Serotonin Uptake Inhibitors
Psychiatric Status Rating Scales
Cognitive Therapy
Mental Disorders
Depressive Disorder
Comorbidity
Severity of Illness Index
Codependency (Psychology)
Clomipramine
Tic Disorders
Somatoform Disorders
Diagnostic and Statistical Manual of Mental Disorders
Personality Inventory
Impulse Control Disorders
Obsessive Hoarding
A cost-effective approach to the use of selective serotonin reuptake inhibitors in a Veterans Affairs Medical Center. (1/695)
In light of the tremendous expansion in the number of selective serotonin reuptake inhibitors available to the clinician, the Pharmacy and Therapeutics Committee of the Denver Veterans Affairs Medical Center considered the advantages and disadvantages of fluoxethine, paroxetine, and sertraline, to determine which agent or agents would be carried on the formulary. The committed recommended sertraline as the preferred agent for the treatment of depression, panic disorders, and obsessive-compulsive disorders. The purpose of this retrospective study was to assess the economic outcome of that decision. The study population consisted of patients at the medical center who were receiving selective serotonin reuptake inhibitors during January through March of 1994 and those were receiving these agents between September 1995 and January 1996. The expanded collection period in 1995-96 was due to a relatively new medical center policy to offer 90-day fills on medication to reduce costs. The extended collection period assured a 100% sample of patients receiving these agents. The 1994 fluoxetine to sertraline dosage equivalency ratio was 20 mg:55.6 mg, based on average daily doses of fluoxetine and sertraline of 32.7 and 90.9 mg, respectively. The cost to the medical center for an average daily dose of fluoxetine was $1.86; sertraline cost $1.22 per day. The 1996 fluoxetine to sertraline dosage equivalency ratio (20 mg:51.3 mg) had not changed significantly since 1994, indicating that the dose of 20 mg of fluoxetine remained very close to a 50-mg dose of sertraline. The average daily doses of fluoxetine and sertraline (34.9 mg and 89.7 mg, respectively) were not significantly different than the 1994 doses. Only 33 patients had been prescribed paroxetine (average daily dose, 32.4 mg). On the basis of these values, the average daily cost of fluoxetine to the medical center was $2.01, compared with $1.18 for sertraline and $1.24 for paroxetine. This $0.83 per patient per day drug acquisition cost difference between fluoxetine and sertraline results in a drug cost reduction of $302,674 per year. (+info)Clarifying an ambiguous functional analysis with matched and mismatched extinction procedures. (2/695)
Results of functional analysis were ambiguous in suggesting that self-injurious behavior (SIB) was maintained by escape, sensory reinforcement, or both. To help clarify these results, we compared escape extinction, sensory extinction, and the combined treatments. Sensory extinction proved to be a necessary and sufficient treatment, whereas escape extinction failed to decrease SIB. These analyses helped to clarify the function of SIB and to identify an effective and efficient treatment. (+info)OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons. (3/695)
To study the behavioral role of neurons containing the D1 dopamine receptor (D1+), we have used a genetic neurostimulatory approach. We generated transgenic mice that express an intracellular form of cholera toxin (CT), a neuropotentiating enzyme that chronically activates stimulatory G-protein (Gs) signal transduction and cAMP synthesis, under the control of the D1 promoter. Because the D1 promoter, like other CNS-expressed promoters, confers transgene expression that is regionally restricted to different D1+ CNS subsets in different transgenic lines, we observed distinct but related psychomotor disorders in different D1CT-expressing founders. In a D1CT line in which transgene expression was restricted to the following D1+ CNS regions-the piriform cortex layer II, layers II-III of somatosensory cortical areas, and the intercalated nucleus of the amygdala-D1CT mice showed normal CNS and D1+ neural architecture but increased cAMP content in whole extracts of the piriform and somatosensory cortex. These mice also exhibited a constellation of compulsive behavioral abnormalities that strongly resembled human cortical-limbic-induced compulsive disorders such as obsessive-compulsive disorder (OCD). These compulsive behaviors included episodes of perseverance or repetition of any and all normal behaviors, repetitive nonaggressive biting of siblings during grooming, and repetitive leaping. These results suggest that chronic potentiation of cortical and limbic D1+ neurons thought to induce glutamatergic output to the striatum causes behaviors reminiscent of those in human cortical-limbic-induced compulsive disorders. (+info)Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. (4/695)
The therapeutic effectiveness of antidepressant drugs in major depression was discovered by pure serendipity. It took over 20 years before the neurobiological modifications that could mediate the antidepressive response were put into evidence. Indeed, whereas the immediate biochemical effects of these drugs had been well documented, their antidepressant action generally does not become apparent before 2 to 3 weeks of treatment. The different classes of antidepressant treatments were subsequently shown to enhance serotonin neurotransmission albeit via different pre- and postsynaptic mechanisms. Clinical trials based on this hypothesis led to the development of treatment strategies producing greater efficacy and more rapid onset of antidepressant action; that, is lithium addition and pindolol combination, respectively. It is expected that the better understanding recently obtained of the mechanism of action of certain antidepressant drugs in obsessive-compulsive and panic disorders will also lead to more effective treatment strategies for those disorders. (+info)A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. (5/695)
Gilles de la Tourette syndrome is a neuropsychiatric disorder characterized by waxing and waning multiple motor and phonic tics with a complex mode of inheritance. Previous attempts, which used large multigenerational families to localize susceptibility loci, have been unsuccessful. In this report, the results of the first systematic genome scan, using 76 affected-sib-pair families with a total of 110 sib pairs, are summarized. While no results reached acceptable statistical significance, the multipoint maximum-likelihood scores (MLS) for two regions (4q and 8p) were suggestive (MLS > 2.0). Four additional genomic regions also gave multipoint MLS scores between 1.0 and 2.0. (+info)Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. (6/695)
Previous positron emission tomography (PET) studies of patients with obsessive-compulsive disorder (OCD) have found elevated glucose metabolic rates in the orbitofrontal cortex (OFC) and caudate nuclei that normalize with response to treatment. Furthermore, OCD symptom provocation differentially activates specific subregions of the OFC, which have distinct patterns of connectivity and serve different functions. Therefore, we sought to determine the role of specific subregions of the OFC and associated subcortical structures in mediating OCD symptoms, by determining how glucose metabolism in these structures changed with paroxetine treatment of OCD patients. We also sought to determine whether pretreatment OFC metabolism would predict response to paroxetine, as it has for other OCD treatments. Twenty subjects with OCD received [18F]-fluorodeoxyglucose (FDG)-PET scans before and after 8 to 12 weeks of treatment with paroxetine, 40 mg/day. In patients who responded to paroxetine, glucose metabolism decreased significantly in right anterolateral OFC and right caudate nucleus. Lower pretreatment metabolism in both left and right OFC predicted greater improvement in OCD severity with treatment. These results add to evidence indicating that orbitofrontal-subcortical circuit function mediates the symptomatic expression of OCD. Specific subregions of the OFC may be differentially involved in the pathophysiology of OCD and/or its response to pharmacotherapy. (+info)Psychotic episodes during zonisamide treatment. (7/695)
Several articles have appeared over the last years devoted to mental side effects during zonisamide (ZNS) treatment. In this study, we were particularly interested in psychotic episodes. Seventy-four epileptic patients with a history of ZNS treatment were surveyed retrospectively over the period spanning 1 March 1984 to 30 June 1994. They were divided into two groups according to the presence or absence of psychotic episodes during ZNS treatment. We analysed various factors pertaining to psychotic episodes during ZNS treatment. Of the 74 patients 14 had psychotic episodes. We found that the incidence of psychotic episodes during ZNS treatment was several times higher than the previously reported prevalence of epileptic psychosis, and that the risk of psychotic episodes was higher in young patients. In 13 patients, psychotic episodes occurred within a few years of commencement of ZNS. In children, obsessive-compulsive symptoms appeared to be related to psychotic episodes. It is important to terminate ZNS as soon as possible if psychotic episodes develop and never restart, even if seizures become worse. It cannot definitely be proved that ZNS causes psychotic episodes, as information on mental side effects during ZNS monotherapy is scant, but it does appear likely that ZNS contributes to psychotic episodes during polytherapy. (+info)Obsessive-compulsive disorder and delusions revisited. (8/695)
BACKGROUND: The concept of fixed, unshakeable (delusional) beliefs within the context of obsessive-compulsive disorder (OCD) is one that has received varying amounts of attention in the literature, and has not yet received universal acknowledgement. There are good grounds for including these cases within the diagnostic concepts of OCD, with significant implications for clinical management. AIMS: To present cases with unusual OCD, in order to re-evaluate the issue of delusions and OCD. METHOD: The cases of five subjects with delusions in the course of obsessive-compulsive disorder are presented to illustrate 'delusional' OCD. The management and outcome of these cases are discussed. RESULTS: Fixity and bizarreness of beliefs in OCD occur on a continuum from 'none' to 'delusional intensity' and may fluctuate within subjects. CONCLUSIONS: The idea that these cases may represent a form of OCD has implications for management, as, if this is correct, they should be able to respond to appropriate behavioural and/or pharmacological strategies used in OCD. (+info)Obsessive-Compulsive Disorder (OCD) is a mental health disorder characterized by the presence of obsessions and compulsions. Obsessions are recurrent and persistent thoughts, urges, or images that are intrusive, unwanted, and often distressing. Compulsions are repetitive behaviors or mental acts that an individual feels driven to perform in response to an obsession or according to rigid rules, and which are aimed at preventing or reducing anxiety or distress, or preventing some dreaded event or situation. These obsessions and/or compulsions cause significant distress, take up a lot of time (an hour or more a day), and interfere with the individual's daily life, including social activities, relationships, and work or school performance. OCD is considered a type of anxiety disorder and can also co-occur with other mental health conditions.
Compulsive behavior is a type of repetitive behavior that an individual feels driven to perform, despite its negative impact on their daily life and mental health. It is often driven by an overwhelming urge or anxiety, and the person may experience distress if they are unable to carry out the behavior. Compulsive behaviors can be associated with various psychiatric conditions, including obsessive-compulsive disorder (OCD), body dysmorphic disorder, eating disorders, and impulse control disorders.
Examples of compulsive behaviors include:
1. Excessive handwashing or cleaning
2. Repeatedly checking locks, light switches, or appliances
3. Ordering or arranging items in a specific way
4. Compulsive hoarding
5. Compulsive shopping or spending
6. Compulsive eating or purging behaviors (such as those seen in bulimia nervosa)
7. Compulsive sexual behavior (sex addiction)
8. Compulsive exercise
9. Compulsive hair pulling (trichotillomania)
10. Compulsive skin picking (excoriation disorder)
Treatment for compulsive behaviors typically involves a combination of medication, psychotherapy (such as cognitive-behavioral therapy), and lifestyle changes to help manage the underlying causes and reduce the urge to engage in the compulsive behavior.
Compulsive Personality Disorder (CPD) is a mental health condition characterized by an obsessive need for order, control, and perfection, which can interfere with the individual's ability to function in daily life. The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), classifies CPD as a type of personality disorder.
The following are some of the diagnostic criteria for Compulsive Personality Disorder:
1. Rigid adherence to rules, regulations, and schedules.
2. Overconscientiousness, preoccupation with details, and perfectionism that interferes with task completion.
3. Excessive devotion to work and productivity at the expense of leisure activities and friendships.
4. Unwillingness to delegate tasks or to work with others unless they submit to exactly the individual's way of doing things.
5. Rigidity and stubbornness.
6. Inability to discard worn-out or worthless objects even when they have no sentimental value.
7. Reluctance to take vacations or engage in leisure activities due to a fear of something unexpected happening that would disrupt the individual's routine.
8. Overly restrained and inhibited in expressing emotions and affection towards others.
Individuals with CPD may experience significant distress and impairment in social, occupational, and other areas of functioning due to their rigid and inflexible behavior. Treatment typically involves psychotherapy, such as cognitive-behavioral therapy (CBT), which can help individuals learn more adaptive ways of thinking and behaving. In some cases, medication may also be recommended to manage symptoms of anxiety or depression that often co-occur with CPD.
I am not able to find a medical definition for "implosive therapy" as it is not a widely recognized or established term in the field of medicine or psychotherapy. It may be a term specific to certain alternative or unconventional approaches, and I would recommend conducting further research to find more information from reliable sources.
However, in the context of psychotherapy, "implosive therapy" is a technique that was developed by psychiatrist Arnold A. Lazarus as a part of his multimodal therapy approach. It involves the use of imaginal exposure to feared stimuli or situations in order to reduce anxiety and avoidance behaviors. The therapist asks the client to vividly imagine a hierarchy of anxiety-provoking scenarios, starting with less distressing ones and gradually moving towards more anxiety-provoking ones. This process is repeated until the anxiety response to the imagined scenarios decreases or disappears.
It's important to note that implosive therapy should be administered by a qualified mental health professional who has received proper training in this technique, as it can potentially lead to increased distress if not conducted appropriately.
Tourette Syndrome (TS) is a neurological disorder characterized by the presence of multiple motor tics and at least one vocal (phonic) tic. These tics are sudden, repetitive, rapid, involuntary movements or sounds that occur for more than a year and are not due to substance use or other medical conditions. The symptoms typically start before the age of 18, with the average onset around 6-7 years old.
The severity, frequency, and types of tics can vary greatly among individuals with TS and may change over time. Common motor tics include eye blinking, facial grimacing, shoulder shrugging, and head or limb jerking. Vocal tics can range from simple sounds like throat clearing, coughing, or barking to more complex phrases or words.
In some cases, TS may be accompanied by co-occurring conditions such as attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), anxiety, and depression. These associated symptoms can sometimes have a greater impact on daily functioning than the tics themselves.
The exact cause of Tourette Syndrome remains unclear, but it is believed to involve genetic factors and abnormalities in certain brain regions involved in movement control and inhibition. There is currently no cure for TS, but various treatments, including behavioral therapy and medications, can help manage the symptoms and improve quality of life.
Fluvoxamine is a type of antidepressant known as a selective serotonin reuptake inhibitor (SSRI). It works by increasing the levels of serotonin, a neurotransmitter in the brain that helps maintain mental balance. Fluvoxamine is primarily used to treat obsessive-compulsive disorder (OCD) and may also be prescribed for other conditions such as depression, panic disorder, or social anxiety disorder.
The medical definition of Fluvoxamine can be stated as:
Fluvoxamine maleate, a selective serotonin reuptake inhibitor (SSRI), is a psychotropic medication used primarily in the treatment of obsessive-compulsive disorder (OCD). It functions by increasing the availability of serotonin in the synaptic cleft, which subsequently modulates neurotransmission and helps restore emotional balance. Fluvoxamine may also be employed off-label for managing other conditions, such as depression, panic disorder, or social anxiety disorder, subject to clinical judgment and patient needs.
Obsessive behavior is defined in the medical context as repetitive, persistent, and intrusive thoughts, images, or urges that cause distress or anxiety. These obsessions are not simply excessive worries about real-life problems, but rather they are irrational and uncontrollable. Often, individuals with obsessive behavior attempt to ignore or suppress their obsessions, which can lead to increased distress and anxiety. In some cases, the obsessions may become so overwhelming that they interfere with a person's daily life and ability to function.
Obsessive behavior is a key feature of several mental health conditions, including obsessive-compulsive disorder (OCD), body dysmorphic disorder (BDD), and hoarding disorder. In these conditions, the obsessions are often accompanied by compulsive behaviors that are performed in an attempt to alleviate the anxiety or distress caused by the obsessions.
It is important to note that everyone experiences unwanted thoughts or urges from time to time. However, when these thoughts become so frequent and distressing that they interfere with a person's daily life, it may be indicative of an underlying mental health condition. In such cases, it is recommended to seek professional help from a qualified mental health provider.
Serotonin uptake inhibitors (also known as Selective Serotonin Reuptake Inhibitors or SSRIs) are a class of medications primarily used to treat depression and anxiety disorders. They work by increasing the levels of serotonin, a neurotransmitter in the brain that helps regulate mood, appetite, and sleep, among other functions.
SSRIs block the reuptake of serotonin into the presynaptic neuron, allowing more serotonin to be available in the synapse (the space between two neurons) for binding to postsynaptic receptors. This results in increased serotonergic neurotransmission and improved mood regulation.
Examples of SSRIs include fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), citalopram (Celexa), and escitalopram (Lexapro). These medications are generally well-tolerated, with side effects that may include nausea, headache, insomnia, sexual dysfunction, and increased anxiety or agitation. However, they can have serious interactions with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting an SSRI.
Psychiatric Status Rating Scales are standardized assessment tools used by mental health professionals to evaluate and rate the severity of a person's psychiatric symptoms and functioning. These scales provide a systematic and structured approach to measuring various aspects of an individual's mental health, such as mood, anxiety, psychosis, behavior, and cognitive abilities.
The purpose of using Psychiatric Status Rating Scales is to:
1. Assess the severity and improvement of psychiatric symptoms over time.
2. Aid in diagnostic decision-making and treatment planning.
3. Monitor treatment response and adjust interventions accordingly.
4. Facilitate communication among mental health professionals about a patient's status.
5. Provide an objective basis for research and epidemiological studies.
Examples of Psychiatric Status Rating Scales include:
1. Clinical Global Impression (CGI): A brief, subjective rating scale that measures overall illness severity, treatment response, and improvement.
2. Positive and Negative Syndrome Scale (PANSS): A comprehensive scale used to assess the symptoms of psychosis, including positive, negative, and general psychopathology domains.
3. Hamilton Rating Scale for Depression (HRSD) or Montgomery-Åsberg Depression Rating Scale (MADRS): Scales used to evaluate the severity of depressive symptoms.
4. Young Mania Rating Scale (YMRS): A scale used to assess the severity of manic or hypomanic symptoms.
5. Brief Psychiatric Rating Scale (BPRS) or Symptom Checklist-90 Revised (SCL-90-R): Scales that measure a broad range of psychiatric symptoms and psychopathology.
6. Global Assessment of Functioning (GAF): A scale used to rate an individual's overall psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness.
It is important to note that Psychiatric Status Rating Scales should be administered by trained mental health professionals to ensure accurate and reliable results.
Cognitive Therapy (CT) is a type of psychotherapeutic treatment that helps patients understand the thoughts and feelings that influence behaviors. It is a form of talk therapy where the therapist and the patient work together to identify and change negative or distorted thinking patterns and beliefs, with the goal of improving emotional response and behavior.
Cognitive Therapy is based on the idea that our thoughts, feelings, and behaviors are all interconnected, and that negative or inaccurate thoughts can contribute to problems like anxiety and depression. By identifying and challenging these thoughts, patients can learn to think more realistically and positively, which can lead to improvements in their mood and behavior.
In cognitive therapy sessions, the therapist will help the patient identify negative thought patterns and replace them with healthier, more accurate ways of thinking. The therapist may also assign homework or exercises for the patient to practice between sessions, such as keeping a thought record or challenging negative thoughts.
Cognitive Therapy has been shown to be effective in treating a wide range of mental health conditions, including depression, anxiety disorders, eating disorders, and post-traumatic stress disorder (PTSD). It is often used in combination with other forms of treatment, such as medication, and can be delivered individually or in group settings.
Anxiety disorders are a category of mental health disorders characterized by feelings of excessive and persistent worry, fear, or anxiety that interfere with daily activities. They include several different types of disorders, such as:
1. Generalized Anxiety Disorder (GAD): This is characterized by chronic and exaggerated worry and tension, even when there is little or nothing to provoke it.
2. Panic Disorder: This is characterized by recurring unexpected panic attacks and fear of experiencing more panic attacks.
3. Social Anxiety Disorder (SAD): Also known as social phobia, this is characterized by excessive fear, anxiety, or avoidance of social situations due to feelings of embarrassment, self-consciousness, and concern about being judged or viewed negatively by others.
4. Phobias: These are intense, irrational fears of certain objects, places, or situations. When a person with a phobia encounters the object or situation they fear, they may experience panic attacks or other severe anxiety responses.
5. Agoraphobia: This is a fear of being in places where it may be difficult to escape or get help if one has a panic attack or other embarrassing or incapacitating symptoms.
6. Separation Anxiety Disorder (SAD): This is characterized by excessive anxiety about separation from home or from people to whom the individual has a strong emotional attachment (such as a parent, sibling, or partner).
7. Selective Mutism: This is a disorder where a child becomes mute in certain situations, such as at school, but can speak normally at home or with close family members.
These disorders are treatable with a combination of medication and psychotherapy (cognitive-behavioral therapy, exposure therapy). It's important to seek professional help if you suspect that you or someone you know may have an anxiety disorder.
A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.
A depressive disorder is a mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest or pleasure in activities. It can also include changes in sleep, appetite, energy levels, concentration, and self-esteem, as well as thoughts of death or suicide. Depressive disorders can vary in severity and duration, with some people experiencing mild and occasional symptoms, while others may have severe and chronic symptoms that interfere with their ability to function in daily life.
There are several types of depressive disorders, including major depressive disorder (MDD), persistent depressive disorder (PDD), and postpartum depression. MDD is characterized by symptoms that interfere significantly with a person's ability to function and last for at least two weeks, while PDD involves chronic low-grade depression that lasts for two years or more. Postpartum depression occurs in women after childbirth and can range from mild to severe.
Depressive disorders are thought to be caused by a combination of genetic, biological, environmental, and psychological factors. Treatment typically involves a combination of medication, psychotherapy (talk therapy), and lifestyle changes.
Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.
A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.
Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.
It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.
Clomipramine is a tricyclic antidepressant drug that is primarily used to treat obsessive-compulsive disorder (OCD). It works by increasing the levels of certain neurotransmitters, such as serotonin and norepinephrine, in the brain. These neurotransmitters are involved in regulating mood and behavior.
Clomipramine is also used off-label to treat other conditions, including panic disorder, depression, chronic pain, and sleep disorders. It is available as a tablet or capsule and is typically taken one to three times a day. Common side effects of clomipramine include dry mouth, constipation, blurred vision, dizziness, and drowsiness.
As with all medications, clomipramine should be used under the close supervision of a healthcare provider, who can monitor its effectiveness and potential side effects. It is important to follow the dosage instructions carefully and to report any unusual symptoms or concerns to the healthcare provider promptly.
Tic disorders are a group of conditions characterized by the presence of repetitive, involuntary movements or sounds, known as tics. These movements or sounds can vary in complexity and severity, and they may be worsened by stress or strong emotions.
There are several different types of tic disorders, including:
1. Tourette's disorder: This is a neurological condition characterized by the presence of both motor (movement-related) and vocal tics that have been present for at least one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
2. Persistent (chronic) motor or vocal tic disorder: This type of tic disorder is characterized by the presence of either motor or vocal tics (but not both), which have been present for at least one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
3. Provisional tic disorder: This type of tic disorder is characterized by the presence of motor or vocal tics (or both) that have been present for less than one year. The tics may wax and wane in severity over time, but they do not disappear for more than three consecutive months.
4. Tic disorder not otherwise specified: This category is used to describe tic disorders that do not meet the criteria for any of the other types of tic disorders.
Tic disorders are thought to be caused by a combination of genetic and environmental factors, and they often co-occur with other conditions such as attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). Treatment for tic disorders may include behavioral therapy, medication, or a combination of both.
Somatoform disorders are a group of psychological disorders characterized by the presence of physical symptoms that cannot be fully explained by a medical condition or substance abuse. These symptoms cause significant distress and impairment in social, occupational, or other important areas of functioning. The individual's belief about the symptoms is not consistent with the medical evaluation and often leads to excessive or repeated medical evaluations.
Examples of somatoform disorders include:
1. Somatization disorder: characterized by multiple physical symptoms that cannot be explained medically, affecting several parts of the body.
2. Conversion disorder: characterized by the presence of one or more neurological symptoms (such as blindness, paralysis, or difficulty swallowing) that cannot be explained medically and appear to have a psychological origin.
3. Pain disorder: characterized by chronic pain that is not fully explained by a medical condition.
4. Hypochondriasis: characterized by an excessive preoccupation with having a serious illness, despite reassurance from medical professionals.
5. Body dysmorphic disorder: characterized by the obsessive idea that some aspect of one's own body part or appearance is severely flawed and warrants exceptional measures to hide or fix it.
It's important to note that these disorders are not caused by intentional deceit or malingering, but rather reflect a genuine belief in the presence of physical symptoms and distress related to them.
The Diagnostic and Statistical Manual of Mental Disorders (DSM) is a publication of the American Psychiatric Association (APA) that provides diagnostic criteria for mental disorders. It is widely used by mental health professionals in the United States and around the world to diagnose and classify mental health conditions.
The DSM includes detailed descriptions of symptoms, clinical examples, and specific criteria for each disorder, which are intended to facilitate accurate diagnosis and improve communication among mental health professionals. The manual is regularly updated to reflect current research and clinical practice, with the most recent edition being the DSM-5, published in 2013.
It's important to note that while the DSM is a valuable tool for mental health professionals, it is not without controversy. Some critics argue that the manual medicalizes normal human experiences and that its categories may be too broad or overlapping. Nonetheless, it remains an essential resource for clinicians, researchers, and policymakers in the field of mental health.
A Personality Inventory is a standardized test used in psychology to assess an individual's personality traits and characteristics. It typically consists of a series of multiple-choice questions or statements that the respondent must rate according to their level of agreement or disagreement. The inventory measures various aspects of an individual's behavior, attitudes, and temperament, providing a quantifiable score that can be compared to normative data to help diagnose personality disorders, assess personal strengths and weaknesses, or provide insights into an individual's likely responses to different situations. Examples of well-known personality inventories include the Minnesota Multiphasic Personality Inventory (MMPI) and the California Psychological Inventory (CPI).
Impulse Control Disorders (ICDs) are a group of psychiatric conditions characterized by the failure to resist an impulse, drive, or temptation to perform an act that is harmful to oneself or others. This leads to negative consequences such as distress, anxiety, or disruption in social, occupational, or other important areas of functioning.
The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) recognizes several specific ICDs, including:
1. Kleptomania - the recurrent failure to resist impulses to steal items, even though they are not needed for personal use or financial gain.
2. Pyromania - the deliberate and purposeful fire-setting on more than one occasion.
3. Intermittent Explosive Disorder - recurrent behavioral outbursts representing a failure to control aggressive impulses, resulting in serious assaultive acts or destruction of property.
4. Pathological Gambling - persistent and recurrent maladaptive gambling behavior that disrupts personal, family, or vocational pursuits.
5. Internet Gaming Disorder - the excessive and prolonged use of the internet for gaming, which leads to clinically significant impairment or distress.
These disorders are typically associated with a range of emotional, cognitive, and behavioral symptoms that can vary depending on the specific disorder and individual presentation. Treatment often involves a combination of psychotherapy, medication, and self-help strategies to manage symptoms and improve overall functioning.
Obsessive Hoarding, also known as Hoarding Disorder, is defined in the medical field as a persistent difficulty in discarding or parting with possessions, regardless of their actual value. This results in an accumulation of items that fill up and clutter living areas to the point where they become difficult to use. The hoarding behavior causes significant distress and impairment in social, occupational, or other important areas of functioning. It is also often associated with symptoms of obsessive-compulsive disorder, depression, and anxiety.
Psychometrics is a branch of psychology that deals with the theory and technique of psychological measurement, such as the development and standardization of tests used to measure intelligence, aptitude, personality, attitudes, and other mental abilities or traits. It involves the construction and validation of measurement instruments, including the determination of their reliability and validity, and the application of statistical methods to analyze test data and interpret results. The ultimate goal of psychometrics is to provide accurate, objective, and meaningful measurements that can be used to understand individual differences and make informed decisions in educational, clinical, and organizational settings.